$1.62
0.02[1.25%]
At close: Apr 29
Chromocell Therapeutics
(AMEX:CHRO)Chromocell Therapeutics Stock (AMEX:CHRO), Quotes and News Summary
Chromocell Therapeutics Stock (AMEX: CHRO) stock price, news, charts, stock research, profile.
| Open | $1.610 |
| Close | $1.620 |
| Volume / Avg. | 5.215K / 33.686K |
| Day Range | 1.560 - 1.733 |
| 52 Wk Range | 1.210 - 6.000 |
| Market Cap | $9.522M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | AMEX |
| RSI | 37 |
| Short Interest | 0.06% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Chromocell Therapeutics Corp.
Sector
Health Care
Industry
Biotechnology
Chromocell Therapeutics Corp is a clinical-stage biotechnology company focused on developing and com...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Chromocell Therapeutics (CHRO) stock?
You can purchase shares of Chromocell Therapeutics (AMEX: CHRO) through any online brokerage.
Who are Chromocell Therapeutics's (CHRO) competitors?
Other companies in Chromocell Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Monopar Therapeutics (NASDAQ:MNPR), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
What is the target price for Chromocell Therapeutics (CHRO) stock?
There is no analysis for Chromocell Therapeutics.
Current Stock Price for Chromocell Therapeutics (CHRO)?
The stock price for Chromocell Therapeutics (AMEX: CHRO) is $1.62 last updated Today at April 29, 2024 at 8:00 PM EDT.
Does Chromocell Therapeutics (CHRO) pay a dividend?
There are no upcoming dividends for Chromocell Therapeutics.
When is Chromocell Therapeutics (AMEX:CHRO) reporting earnings?
Chromocell Therapeutics’s Q1 earnings are confirmed for Monday, May 20, 2024.
Is Chromocell Therapeutics (CHRO) going to split?
There is no upcoming split for Chromocell Therapeutics.
What sector and industry does Chromocell Therapeutics (CHRO) operate in?
Chromocell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.